This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TherapeuticsMD Announces Webcast For Investor Day On June 16, 2014

TherapeuticsMD, Inc. (NYSE MKT:TXMD) a women’s health care company, ("TherapeuticsMD" or the "Company") announced today that it will webcast its upcoming Investor Day on June 16, 2014 to be held at the InterContinental Barclay New York in New York City commencing promptly at 11:30 a.m. EDT to approximately 2:30 p.m.

At the event, TherapeuticsMD's senior management team will make remarks regarding the Company's product development pipeline and future prospects. The event will feature a panel of prominent experts on women’s health and hormone therapy, the compounding market, and relevant legislative and regulatory topics. The presentation may include forward-looking statements.

Institutional investors and analysts who would like to attend in person may register by contacting Lisa Wilson at 917-543-9932 or by e-mail at lwilson@insitecony.com, or may register online at the home page of the Company's website at www.TherapeuticsMD.com. For individuals attending in person, onsite registration and lunch will begin at 11:00 a.m. with the presentation commencing promptly at 11:30 a.m.

Investors and other interested parties who are unable to attend in person are invited to participate in a simultaneous webcast through the Company's website at www.TherapeuticsMD.com, both on the home page and under the Investors tab. It is recommended that online participants in the simultaneous webcast register approximately 15 minutes prior to the scheduled presentation time of 11:30 a.m. to ensure a timely connection. Participants may also submit questions for the question-and-answer segment via e-mail to: lwilson@insitecony.com. The webcast will be archived on the Company’s website for at least one month.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. TherapeuticsMD is developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD ® and BocaGreenMD ® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs